PHILADELPHIA CHROMOSOME POSITIVE
Clinical trials for PHILADELPHIA CHROMOSOME POSITIVE explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA CHROMOSOME POSITIVE trials appear
Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune therapy trial aims to target tough leukemia
Disease control OngoingThis early-stage study is testing the safety and side effects of a new type of immune cell therapy for adults with B-cell acute lymphoblastic leukemia that has come back or hasn't responded to other treatments. The therapy involves genetically modifying a patient's own immune cel…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug combo tested for Tough-to-Treat leukemia
Disease control OngoingThis study is testing a combination of intensive chemotherapy (called Hyper-CVAD) and a targeted drug called ponatinib for adults with a specific type of acute lymphoblastic leukemia (ALL) that involves a genetic change called Philadelphia chromosome or BCR-ABL. The main goal is …
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC